Neogen Corp - Company Profile
Powered by 
All the sales intelligence you need on Neogen Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Neogen Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Neogen Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
The following section provides information on Neogen Corp’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Neogen Corp's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
James C. Borel
Chairman Executive BoardMr. James C. Borel has been the Chairman of the company since 2016. Previously, he served as an Executive Vice President at DuPont. Mr. Borel is a member of multiple boards of directors and is a member of the board of trustees at the University of Delaware and the board of Governors for Iowa State University.
Mike Nassif
President; Chief Executive Officer; Director Executive BoardMr. Mike Nassif has been the Chief Executive Officer, Director and President of the company since August 2025. Previously, he served as Global President of Point of Care Diagnostics at Siemens Healthineers. Prior to this, Mr. Nassif held senior leadership roles at Baxter Healthcare, AB-InBev, and Johnson & Johnson.
R. Bryan Riggsbee
Chief Financial Officer; Senior Vice President Senior ManagementMr. Bryan Riggsbee has been the Chief Financial Officer of the company since 2025. Prior to this, he served as the Chief Financial Officer of bioMerieux and Myriad Genetics. He held senior finance roles at Laboratory Corporation of America (LabCorp), GE, and KPMG. Earlier, he served as an Executive Vice President, Chief Financial Officer and Treasurer of Myriad Genetics, Inc from 2014 to 2024.
Jeremy Yarwood
Chief Scientific Officer Senior ManagementMr. Jeremy Yarwood is the Chief Scientific Officer of the company. Prior to this, he served as the Global Senior Vice President of R&D at Olympus Corporation. Previously, he served as Divisional vice president of R&D at Abbott Point of Care/Rapid and Molecular Diagnostics.
Jennifer Evans Stacey
Chief Legal and Compliance Officer; Senior Vice President; Secretary Senior ManagementMs. Evans Stacey as Chief Legal and Compliance Officer, Senior Vice President and Board Secretary of the company April 2026. Prior to this, she served as the Chief Legal and Compliance Officer and Secretary at Galera Therapeutics, Inc. Previously, she held the Chief Legal Officer roles at The Wistar Institute, Antares Pharma, Inc., FXI, Inc., Auxilium Pharmaceuticals, Inc., and Aventis Behring LLC. Jennifer currently serves on the Board of Directors of Context Therapeutics.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer